カテゴリー： Market Monitor Global, 世界, 医療/バイオ

T細胞誘導bsAbs薬の世界市場見通し2023年-2029年

◆英語タイトル：T-cell engaging bsAbs Drugs Market, Global Outlook and Forecast 2023-2029
	◆商品コード：MMG23LY8700 ◆発行会社（リサーチ会社）：Market Monitor Global ◆発行日：2023年7月（※2025年版があります。お問い合わせください。） ◆ページ数：75 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後2-3営業日） ◆調査対象地域：グローバル ◆産業分野：医薬品＆ヘルスケア

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥487,500	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥633,750	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥731,250	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global T-cell engaging bsAbs Drugs Market 調査レポートは次の情報を含め、グローバルにおけるのT細胞誘導bsAbs薬市場規模と予測を収録しています。・世界のT細胞誘導bsAbs薬市場：売上、2018年-2023年、2024年-2029年
・世界のT細胞誘導bsAbs薬市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のT細胞誘導bsAbs薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「ブリンサイト」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

T細胞誘導bsAbs薬のグローバル主要企業は、Amgen、 Immunocoreなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、T細胞誘導bsAbs薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界のT細胞誘導bsAbs薬市場：タイプ別、2018年-2023年、2024年-2029年
世界のT細胞誘導bsAbs薬市場：タイプ別市場シェア、2022年
・ブリンサイト、キムトラック

世界のT細胞誘導bsAbs薬市場：用途別、2018年-2023年、2024年-2029年
世界のT細胞誘導bsAbs薬市場：用途別市場シェア、2022年
・血液がん、固形がん

世界のT細胞誘導bsAbs薬市場：地域・国別、2018年-2023年、2024年-2029年
世界のT細胞誘導bsAbs薬市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業におけるT細胞誘導bsAbs薬のグローバル売上、2018年-2023年
・主要企業におけるT細胞誘導bsAbs薬のグローバル売上シェア、2022年
・主要企業におけるT細胞誘導bsAbs薬のグローバル販売量、2018年-2023年
・主要企業におけるT細胞誘導bsAbs薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Amgen、 Immunocore

*************************************************************

・調査・分析レポートの概要
T細胞誘導bsAbs薬市場の定義
市場セグメント
世界のT細胞誘導bsAbs薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のT細胞誘導bsAbs薬市場規模
世界のT細胞誘導bsAbs薬市場規模：2022年 VS 2029年
世界のT細胞誘導bsAbs薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのT細胞誘導bsAbs薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のT細胞誘導bsAbs薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：ブリンサイト、キムトラック
T細胞誘導bsAbs薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：血液がん、固形がん
T細胞誘導bsAbs薬の用途別グローバル売上・予測

・地域別市場分析
地域別T細胞誘導bsAbs薬市場規模 2022年と2029年
地域別T細胞誘導bsAbs薬売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Amgen、 Immunocore
...

Bispecific T-cell engager (BiTE) stands out as a novel subclass of T-cell engaging bsAbs with promising clinical results in the treatment of cancers.
This report aims to provide a comprehensive presentation of the global market for T-cell engaging bsAbs Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding T-cell engaging bsAbs Drugs. This report contains market size and forecasts of T-cell engaging bsAbs Drugs in global, including the following market information:
Global T-cell engaging bsAbs Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global T-cell engaging bsAbs Drugs Market Sales, 2018-2023, 2024-2029, (Units)
Global top five T-cell engaging bsAbs Drugs companies in 2022 (%)
The global T-cell engaging bsAbs Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Blincyto Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of T-cell engaging bsAbs Drugs include Amgen and Immunocore etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the T-cell engaging bsAbs Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global T-cell engaging bsAbs Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global T-cell engaging bsAbs Drugs Market Segment Percentages, by Type, 2022 (%)
Blincyto
Kimmtrak
Global T-cell engaging bsAbs Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global T-cell engaging bsAbs Drugs Market Segment Percentages, by Application, 2022 (%)
Hematological Cancers
Solid Tumors
Global T-cell engaging bsAbs Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global T-cell engaging bsAbs Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies T-cell engaging bsAbs Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies T-cell engaging bsAbs Drugs revenues share in global market, 2022 (%)
Key companies T-cell engaging bsAbs Drugs sales in global market, 2018-2023 (Estimated), (Units)
Key companies T-cell engaging bsAbs Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Amgen
Immunocore
Outline of Major Chapters:
Chapter 1: Introduces the definition of T-cell engaging bsAbs Drugs, market overview.
Chapter 2: Global T-cell engaging bsAbs Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of T-cell engaging bsAbs Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of T-cell engaging bsAbs Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global T-cell engaging bsAbs Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 T-cell engaging bsAbs Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global T-cell engaging bsAbs Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global T-cell engaging bsAbs Drugs Overall Market Size
2.1 Global T-cell engaging bsAbs Drugs Market Size: 2022 VS 2029
2.2 Global T-cell engaging bsAbs Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global T-cell engaging bsAbs Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top T-cell engaging bsAbs Drugs Players in Global Market
3.2 Top Global T-cell engaging bsAbs Drugs Companies Ranked by Revenue
3.3 Global T-cell engaging bsAbs Drugs Revenue by Companies
3.4 Global T-cell engaging bsAbs Drugs Sales by Companies
3.5 Global T-cell engaging bsAbs Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 T-cell engaging bsAbs Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers T-cell engaging bsAbs Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 T-cell engaging bsAbs Drugs Players in Global Market
3.8.1 List of Global Tier 1 T-cell engaging bsAbs Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 T-cell engaging bsAbs Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global T-cell engaging bsAbs Drugs Market Size Markets, 2022 & 2029
4.1.2 Blincyto
4.1.3 Kimmtrak
4.2 By Type – Global T-cell engaging bsAbs Drugs Revenue & Forecasts
4.2.1 By Type – Global T-cell engaging bsAbs Drugs Revenue, 2018-2023
4.2.2 By Type – Global T-cell engaging bsAbs Drugs Revenue, 2024-2029
4.2.3 By Type – Global T-cell engaging bsAbs Drugs Revenue Market Share, 2018-2029
4.3 By Type – Global T-cell engaging bsAbs Drugs Sales & Forecasts
4.3.1 By Type – Global T-cell engaging bsAbs Drugs Sales, 2018-2023
4.3.2 By Type – Global T-cell engaging bsAbs Drugs Sales, 2024-2029
4.3.3 By Type – Global T-cell engaging bsAbs Drugs Sales Market Share, 2018-2029
4.4 By Type – Global T-cell engaging bsAbs Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global T-cell engaging bsAbs Drugs Market Size, 2022 & 2029
5.1.2 Hematological Cancers
5.1.3 Solid Tumors
5.2 By Application – Global T-cell engaging bsAbs Drugs Revenue & Forecasts
5.2.1 By Application – Global T-cell engaging bsAbs Drugs Revenue, 2018-2023
5.2.2 By Application – Global T-cell engaging bsAbs Drugs Revenue, 2024-2029
5.2.3 By Application – Global T-cell engaging bsAbs Drugs Revenue Market Share, 2018-2029
5.3 By Application – Global T-cell engaging bsAbs Drugs Sales & Forecasts
5.3.1 By Application – Global T-cell engaging bsAbs Drugs Sales, 2018-2023
5.3.2 By Application – Global T-cell engaging bsAbs Drugs Sales, 2024-2029
5.3.3 By Application – Global T-cell engaging bsAbs Drugs Sales Market Share, 2018-2029
5.4 By Application – Global T-cell engaging bsAbs Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global T-cell engaging bsAbs Drugs Market Size, 2022 & 2029
6.2 By Region – Global T-cell engaging bsAbs Drugs Revenue & Forecasts
6.2.1 By Region – Global T-cell engaging bsAbs Drugs Revenue, 2018-2023
6.2.2 By Region – Global T-cell engaging bsAbs Drugs Revenue, 2024-2029
6.2.3 By Region – Global T-cell engaging bsAbs Drugs Revenue Market Share, 2018-2029
6.3 By Region – Global T-cell engaging bsAbs Drugs Sales & Forecasts
6.3.1 By Region – Global T-cell engaging bsAbs Drugs Sales, 2018-2023
6.3.2 By Region – Global T-cell engaging bsAbs Drugs Sales, 2024-2029
6.3.3 By Region – Global T-cell engaging bsAbs Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America T-cell engaging bsAbs Drugs Revenue, 2018-2029
6.4.2 By Country – North America T-cell engaging bsAbs Drugs Sales, 2018-2029
6.4.3 US T-cell engaging bsAbs Drugs Market Size, 2018-2029
6.4.4 Canada T-cell engaging bsAbs Drugs Market Size, 2018-2029
6.4.5 Mexico T-cell engaging bsAbs Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe T-cell engaging bsAbs Drugs Revenue, 2018-2029
6.5.2 By Country – Europe T-cell engaging bsAbs Drugs Sales, 2018-2029
6.5.3 Germany T-cell engaging bsAbs Drugs Market Size, 2018-2029
6.5.4 France T-cell engaging bsAbs Drugs Market Size, 2018-2029
6.5.5 U.K. T-cell engaging bsAbs Drugs Market Size, 2018-2029
6.5.6 Italy T-cell engaging bsAbs Drugs Market Size, 2018-2029
6.5.7 Russia T-cell engaging bsAbs Drugs Market Size, 2018-2029
6.5.8 Nordic Countries T-cell engaging bsAbs Drugs Market Size, 2018-2029
6.5.9 Benelux T-cell engaging bsAbs Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia T-cell engaging bsAbs Drugs Revenue, 2018-2029
6.6.2 By Region – Asia T-cell engaging bsAbs Drugs Sales, 2018-2029
6.6.3 China T-cell engaging bsAbs Drugs Market Size, 2018-2029
6.6.4 Japan T-cell engaging bsAbs Drugs Market Size, 2018-2029
6.6.5 South Korea T-cell engaging bsAbs Drugs Market Size, 2018-2029
6.6.6 Southeast Asia T-cell engaging bsAbs Drugs Market Size, 2018-2029
6.6.7 India T-cell engaging bsAbs Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America T-cell engaging bsAbs Drugs Revenue, 2018-2029
6.7.2 By Country – South America T-cell engaging bsAbs Drugs Sales, 2018-2029
6.7.3 Brazil T-cell engaging bsAbs Drugs Market Size, 2018-2029
6.7.4 Argentina T-cell engaging bsAbs Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa T-cell engaging bsAbs Drugs Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa T-cell engaging bsAbs Drugs Sales, 2018-2029
6.8.3 Turkey T-cell engaging bsAbs Drugs Market Size, 2018-2029
6.8.4 Israel T-cell engaging bsAbs Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia T-cell engaging bsAbs Drugs Market Size, 2018-2029
6.8.6 UAE T-cell engaging bsAbs Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Amgen
7.1.1 Amgen Company Summary
7.1.2 Amgen Business Overview
7.1.3 Amgen T-cell engaging bsAbs Drugs Major Product Offerings
7.1.4 Amgen T-cell engaging bsAbs Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Amgen Key News & Latest Developments
7.2 Immunocore
7.2.1 Immunocore Company Summary
7.2.2 Immunocore Business Overview
7.2.3 Immunocore T-cell engaging bsAbs Drugs Major Product Offerings
7.2.4 Immunocore T-cell engaging bsAbs Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Immunocore Key News & Latest Developments
8 Global T-cell engaging bsAbs Drugs Production Capacity, Analysis
8.1 Global T-cell engaging bsAbs Drugs Production Capacity, 2018-2029
8.2 T-cell engaging bsAbs Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global T-cell engaging bsAbs Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 T-cell engaging bsAbs Drugs Supply Chain Analysis
10.1 T-cell engaging bsAbs Drugs Industry Value Chain
10.2 T-cell engaging bsAbs Drugs Upstream Market
10.3 T-cell engaging bsAbs Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 T-cell engaging bsAbs Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of T-cell engaging bsAbs Drugs in Global Market
Table 2. Top T-cell engaging bsAbs Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global T-cell engaging bsAbs Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global T-cell engaging bsAbs Drugs Revenue Share by Companies, 2018-2023
Table 5. Global T-cell engaging bsAbs Drugs Sales by Companies, (Units), 2018-2023
Table 6. Global T-cell engaging bsAbs Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers T-cell engaging bsAbs Drugs Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers T-cell engaging bsAbs Drugs Product Type
Table 9. List of Global Tier 1 T-cell engaging bsAbs Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 T-cell engaging bsAbs Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global T-cell engaging bsAbs Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global T-cell engaging bsAbs Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global T-cell engaging bsAbs Drugs Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global T-cell engaging bsAbs Drugs Sales (Units), 2018-2023
Table 15. By Type - Global T-cell engaging bsAbs Drugs Sales (Units), 2024-2029
Table 16. By Application – Global T-cell engaging bsAbs Drugs Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global T-cell engaging bsAbs Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global T-cell engaging bsAbs Drugs Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global T-cell engaging bsAbs Drugs Sales (Units), 2018-2023
Table 20. By Application - Global T-cell engaging bsAbs Drugs Sales (Units), 2024-2029
Table 21. By Region – Global T-cell engaging bsAbs Drugs Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global T-cell engaging bsAbs Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global T-cell engaging bsAbs Drugs Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global T-cell engaging bsAbs Drugs Sales (Units), 2018-2023
Table 25. By Region - Global T-cell engaging bsAbs Drugs Sales (Units), 2024-2029
Table 26. By Country - North America T-cell engaging bsAbs Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America T-cell engaging bsAbs Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America T-cell engaging bsAbs Drugs Sales, (Units), 2018-2023
Table 29. By Country - North America T-cell engaging bsAbs Drugs Sales, (Units), 2024-2029
Table 30. By Country - Europe T-cell engaging bsAbs Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe T-cell engaging bsAbs Drugs Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe T-cell engaging bsAbs Drugs Sales, (Units), 2018-2023
Table 33. By Country - Europe T-cell engaging bsAbs Drugs Sales, (Units), 2024-2029
Table 34. By Region - Asia T-cell engaging bsAbs Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia T-cell engaging bsAbs Drugs Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia T-cell engaging bsAbs Drugs Sales, (Units), 2018-2023
Table 37. By Region - Asia T-cell engaging bsAbs Drugs Sales, (Units), 2024-2029
Table 38. By Country - South America T-cell engaging bsAbs Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America T-cell engaging bsAbs Drugs Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America T-cell engaging bsAbs Drugs Sales, (Units), 2018-2023
Table 41. By Country - South America T-cell engaging bsAbs Drugs Sales, (Units), 2024-2029
Table 42. By Country - Middle East & Africa T-cell engaging bsAbs Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa T-cell engaging bsAbs Drugs Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa T-cell engaging bsAbs Drugs Sales, (Units), 2018-2023
Table 45. By Country - Middle East & Africa T-cell engaging bsAbs Drugs Sales, (Units), 2024-2029
Table 46. Amgen Company Summary
Table 47. Amgen T-cell engaging bsAbs Drugs Product Offerings
Table 48. Amgen T-cell engaging bsAbs Drugs Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Amgen Key News & Latest Developments
Table 50. Immunocore Company Summary
Table 51. Immunocore T-cell engaging bsAbs Drugs Product Offerings
Table 52. Immunocore T-cell engaging bsAbs Drugs Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Immunocore Key News & Latest Developments
Table 54. T-cell engaging bsAbs Drugs Production Capacity (Units) of Key Manufacturers in Global Market, 2021-2023 (Units)
Table 55. Global T-cell engaging bsAbs Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 56. Global T-cell engaging bsAbs Drugs Production by Region, 2018-2023 (Units)
Table 57. Global T-cell engaging bsAbs Drugs Production by Region, 2024-2029 (Units)
Table 58. T-cell engaging bsAbs Drugs Market Opportunities & Trends in Global Market
Table 59. T-cell engaging bsAbs Drugs Market Drivers in Global Market
Table 60. T-cell engaging bsAbs Drugs Market Restraints in Global Market
Table 61. T-cell engaging bsAbs Drugs Raw Materials
Table 62. T-cell engaging bsAbs Drugs Raw Materials Suppliers in Global Market
Table 63. Typical T-cell engaging bsAbs Drugs Downstream
Table 64. T-cell engaging bsAbs Drugs Downstream Clients in Global Market
Table 65. T-cell engaging bsAbs Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. T-cell engaging bsAbs Drugs Segment by Type in 2022
Figure 2. T-cell engaging bsAbs Drugs Segment by Application in 2022
Figure 3. Global T-cell engaging bsAbs Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global T-cell engaging bsAbs Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global T-cell engaging bsAbs Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. T-cell engaging bsAbs Drugs Sales in Global Market: 2018-2029 (Units)
Figure 8. The Top 3 and 5 Players Market Share by T-cell engaging bsAbs Drugs Revenue in 2022
Figure 9. By Type - Global T-cell engaging bsAbs Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global T-cell engaging bsAbs Drugs Revenue Market Share, 2018-2029
Figure 11. By Type - Global T-cell engaging bsAbs Drugs Sales Market Share, 2018-2029
Figure 12. By Type - Global T-cell engaging bsAbs Drugs Price (US$/Unit), 2018-2029
Figure 13. By Application - Global T-cell engaging bsAbs Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global T-cell engaging bsAbs Drugs Revenue Market Share, 2018-2029
Figure 15. By Application - Global T-cell engaging bsAbs Drugs Sales Market Share, 2018-2029
Figure 16. By Application - Global T-cell engaging bsAbs Drugs Price (US$/Unit), 2018-2029
Figure 17. By Region - Global T-cell engaging bsAbs Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global T-cell engaging bsAbs Drugs Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global T-cell engaging bsAbs Drugs Revenue Market Share, 2018-2029
Figure 20. By Region - Global T-cell engaging bsAbs Drugs Sales Market Share, 2018-2029
Figure 21. By Country - North America T-cell engaging bsAbs Drugs Revenue Market Share, 2018-2029
Figure 22. By Country - North America T-cell engaging bsAbs Drugs Sales Market Share, 2018-2029
Figure 23. US T-cell engaging bsAbs Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Canada T-cell engaging bsAbs Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico T-cell engaging bsAbs Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe T-cell engaging bsAbs Drugs Revenue Market Share, 2018-2029
Figure 27. By Country - Europe T-cell engaging bsAbs Drugs Sales Market Share, 2018-2029
Figure 28. Germany T-cell engaging bsAbs Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. France T-cell engaging bsAbs Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. T-cell engaging bsAbs Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Italy T-cell engaging bsAbs Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. Russia T-cell engaging bsAbs Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries T-cell engaging bsAbs Drugs Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux T-cell engaging bsAbs Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia T-cell engaging bsAbs Drugs Revenue Market Share, 2018-2029
Figure 36. By Region - Asia T-cell engaging bsAbs Drugs Sales Market Share, 2018-2029
Figure 37. China T-cell engaging bsAbs Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Japan T-cell engaging bsAbs Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea T-cell engaging bsAbs Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia T-cell engaging bsAbs Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. India T-cell engaging bsAbs Drugs Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America T-cell engaging bsAbs Drugs Revenue Market Share, 2018-2029
Figure 43. By Country - South America T-cell engaging bsAbs Drugs Sales Market Share, 2018-2029
Figure 44. Brazil T-cell engaging bsAbs Drugs Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina T-cell engaging bsAbs Drugs Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa T-cell engaging bsAbs Drugs Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa T-cell engaging bsAbs Drugs Sales Market Share, 2018-2029
Figure 48. Turkey T-cell engaging bsAbs Drugs Revenue, (US$, Mn), 2018-2029
Figure 49. Israel T-cell engaging bsAbs Drugs Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia T-cell engaging bsAbs Drugs Revenue, (US$, Mn), 2018-2029
Figure 51. UAE T-cell engaging bsAbs Drugs Revenue, (US$, Mn), 2018-2029
Figure 52. Global T-cell engaging bsAbs Drugs Production Capacity (Units), 2018-2029
Figure 53. The Percentage of Production T-cell engaging bsAbs Drugs by Region, 2022 VS 2029
Figure 54. T-cell engaging bsAbs Drugs Industry Value Chain
Figure 55. Marketing Channels

※参考情報

T細胞誘導bsAbs（バイスぺシフィック抗体）薬は、近年のがん免疫療法の進歩において注目を集めている治療法の一つです。これらの薬剤は、二つの異なる抗原に結合する能力を持ち、特にT細胞とがん細胞を直接結びつけることで、免疫系ががん細胞を標的にしやすくする機構を持っています。以下にその概念を詳しく説明いたします。

まず、T細胞誘導bsAbsとは、一対の異なる抗原に特異的に結合する抗体の一種です。これは、一つの抗体がT細胞のCD3受容体とがん細胞の特定の抗原に同時に結合することを可能にし、免疫系を活性化させることを目的としています。この機構により、T細胞ががん細胞に対する効果的な攻撃を行えるようにサポートするのです。

T細胞誘導bsAbs薬の特徴としては、まずその高い特異性が挙げられます。T細胞の活性化ががん細胞に特異的に誘導されるため、正常な細胞へのダメージが比較的少なく、治療に伴う副作用が軽減される可能性があります。また、この薬の効果は、患者自身の免疫系を利用するため、がん細胞に対する持続的な免疫応答を誘導することが期待されます。

T細胞誘導bsAbsは、いくつかの種類に分類されます。代表的な製品としては、ブリストル・マイヤーズスクイブ社の「ブリントゥスビ（Blinatumomab）」があります。これは急性リンパ性白血病（ALL）の治療に使用され、CD19とCD3を結合することにより、リンパ球の白血病細胞を標的にします。他にも、多くの研究開発段階にあるbsAbsがあります。それぞれが異なる抗原とT細胞をターゲットにしており、様々ながんの治療に向けた期待が寄せられています。

用途としては、主にがん療法においての利用が最も顕著ですが、最近では自己免疫疾患などの分野にも応用の可能性が模索されています。特にがん治療においては、従来の化学療法や放射線療法と比較して、がん細胞に対する選択的な攻撃を行うことができるため、患者にとっての利点が大きいとされています。また、現在用いられている標的治療や免疫チェックポイント阻害剤と併用することにより、より高い治療効果が期待されています。

関連技術としては、抗体工学の進展が挙げられます。これにより、特定の抗原に対する高親和性を有する抗体を作製する技術が発展し、それを組み合わせることでbsAbsがより効果的に設計されるようになりました。また、ヒト化抗体技術や遺伝子工学も利用され、より安全で効果的な治療法の開発が進められています。また、T細胞誘導bsAbsの効果を最大限に引き出すために、体内のT細胞環境を調整するためのオプションとして、サイトカイン療法や他の免疫療法との併用も検討されています。

T細胞誘導bsAbs薬は、がん治療における新たな選択肢として注目されており、今後の研究開発が期待される領域です。具体的には、様々ながんタイプに対する適応の拡大や、治療効果の向上、さらには副作用の低減が目指されています。この新しいアプローチにより、治療が難しいがん患者にとって新たな希望がもたらされることが期待されています。

総じて、T細胞誘導bsAbs薬は、現代医学におけるがん治療の革新をもたらす重要なツールであり、引き続き多くの研究が進められることでしょう。特に、臨床での成績や副作用の管理、さらには個別化医療の観点からも、その最適な適応を模索することが必要です。今後もこの分野の進展に目が離せません。

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ T細胞誘導bsAbs薬の世界市場見通し2023年-2029年(T-cell engaging bsAbs Drugs Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

T細胞誘導bsAbs薬の世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp